Frontlight ResearchEarly access
Obesity trials in Italy
104 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffects of "Exercise Snack" in Individuals With Obesity
- Where
- Milan
- Age
- 30 years to 70 years
- People
- 8
- Run by
- Istituto Auxologico Italiano
See details and how to joinNCT07935473 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bari, Bergamo, Brescia, Cortona, Foggia, Forli', Milan, Naples, Parma, Pavia, Rimini, Rivoli, Rome, Rozzano, Sassari
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - No phaseTaking peopleType 2 Diabetes, Obesity and Cortisol Excess
- Where
- Milan, Roma, Siena, Udine
- Age
- 18 years to 75 years
- People
- 3,200
- Run by
- Istituto Auxologico Italiano
See details and how to joinNCT05759637 - No phaseTaking peoplePrecision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols
- Where
- Parma
- Age
- 40 years to 80 years
- People
- 330
- Run by
- University of Parma
See details and how to joinNCT06347094 - Phase 3Active, not recruitingA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Bari, Bergamo, Bologna, Catanzaro, Palermo, Perugia, Pisa, Rome, San Donato Milanese
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Bari, Bergamo, Bologna, Catanzaro, Milan, Palermo, Perugia, Rome
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - No phaseTaking peopleEffects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
- Where
- Oggebbio
- Age
- 65 years and over
- People
- 160
- Run by
- Istituto Auxologico Italiano
See details and how to joinNCT07614464 - No phaseTaking peopleBariatric Surgery and Gut Microbiota Changes Over Time
- Where
- Castellana Grotte
- Age
- 18 years to 65 years
- People
- 100
- Run by
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
See details and how to joinNCT07381140 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Bologna, Chieti Scalo, Palermo, Rome, Sesto San Giovanni
- Age
- 18 years and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - Phase 3Not yet taking people in ItalyA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Where
- Florence, Milan, Palermo, Pisa
- Age
- 18 years and over
- People
- 3,900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843498 · EU 2026-526188-39-00 - Phase 3Not yet taking people in ItalyA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Ancorna, Bari, Brescia, Catanzaro, Ferrara, Milan, Padova, Palermo, Pozzilli (IS), Rome, Siena
- Age
- 18 years and over
- People
- 1,408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - Phase 3Not yet taking people in ItalyA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Florence, Modena, Novara, Parma, Roma, Verona
- Age
- 6 years to 17 years
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - Phase 3Active, not recruitingA Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- Where
- Florence, Novara, Rome, Verona
- Age
- 12 years to 17 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672939 · EU 2024-514081-40-00 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 3Taking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - Phase 3Not yet taking people in ItalyEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Where
- Florence, Modena, Novara, Parma, Roma
- Age
- 6 years to 11 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00 - Phase 3Not yet taking people in ItalyA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Arezzo, Bologna, Chieti Scalo, Florence, Milan, Modena, Naples, Padova, Parma, Pisa, Rome, Rozzano, Siena, A.O.U. Policlinico Paolo Giaccone, Osepdale Civile Fr 5, ASL Città di Torino
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Not yet taking people in ItalyA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bologna, Milan, Palermo, Pisa, Rome, Rozzano, Sesto San Giovanni, Turin
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleInvestigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
- Where
- Novara
- Age
- 18 years and over
- People
- 195
- Run by
- Azienda Ospedaliero Universitaria Maggiore della Carita
See details and how to joinNCT06438900 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples, Parma, Pavia, Rimini, Rivoli, Roma, Sassari
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - No phaseTaking peopleClinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
- Where
- Roma
- Age
- 18 years to 80 years
- People
- 44
- Run by
- University of Roma La Sapienza
See details and how to joinNCT04374721 - No phaseTaking peopleMORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness
- Where
- Pavia
- Age
- 18 years and over
- People
- 34
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07880847 - Phase 3Taking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna, Roma, San Donato
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - No phaseNot yet taking people in ItalyENDOBARIHEART STUDY
- Where
- Cotignola
- Age
- 18 years and over
- People
- 50
- Run by
- Maria Cecilia Hospital
See details and how to joinNCT07847307 - Phase 3Taking peopleA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Acquaviva delle Fonti, Bari, Bergamo, Castellana Grotte, Catanzaro, Chieti Scalo, Cosenza, Ferrara, Florence, Grosseto, Latina, Lucca, Milan, Naples, Negrar, Orbassano, Padova, Rimini, Rome, Salerno, Sesto San Giovanni, Siena, Turin, Venice
- Age
- 45 years to 64 years
- People
- 8,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00